A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
Authors:
Open Access
- 1 March 2018
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 91, 86-91
Abstract
No abstract availableKeywords
Funding Information
- Taiho Pharmaceutical
This publication has 16 references indexed in Scilit:
- Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 studyThe Lancet Oncology, 2017
- A Bayesian network meta-analysis on second-line systemic therapy in advanced gastric cancerGastric Cancer, 2016
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2016
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)Gastric Cancer, 2016
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trialThe Lancet Oncology, 2014
- Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialThe Lancet Oncology, 2014
- Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 TrialJournal of Clinical Oncology, 2013
- Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care AloneJournal of Clinical Oncology, 2012
- Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)European Journal of Cancer, 2011
- Cremophor ELEuropean Journal of Cancer, 2001